Jun 13, 2014
A University of Minnesota research group, led by chief researcher Kalpna Gupta, has found that the cannabinoids in marijuana can help treat pain caused by sickle cell disease, reports Minnesota Daily. The group has been running tests on mice and it has yielded good outcomes from those tests. The study says the next step is to move onto human trials; however, it is running into issues with Minnesota’s laws.
In order to take this next step, the research will be moved to California, where medical marijuana became legal almost 20 years ago. Minnesota, on the other hand, has a stricter medical marijuana law that will take effect next summer. This research may actually affect the Minnesota law, however, by providing evidence that could help add sickle cell disease to the qualifying health conditions for the program.
The conditions currently approved by Minnesota law include cancer, HIV/AIDS, glaucoma, and seizures. The Department of Health in Minnesota is presently creating a task force to investigate the therapeutic effects of marijuana. Dr. Gupta’s research is being funded by the National Institute of Health’s grant, and is intended to test the effects of vaporized marijuana on 35 sickle cell disease patients at the beginning of July. Minnesota’s medical marijuana laws are some of the strictest in the nation, but the research Dr. Gupta is doing may be able to help more patients find relief.